Perovskite luminescent nanocrystal, light emitting device, and manufacturing method for perovskite luminescent nanocrystal

US10808172B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10808172-B2
Application numberUS-201916566903-A
CountryUS
Kind codeB2
Filing dateSep 11, 2019
Priority dateJan 31, 2019
Publication dateOct 20, 2020
Grant dateOct 20, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A perovskite luminescent nanocrystal has a chemical formula represented by: Cs 4 BX 6 , wherein B includes one or more selected from the group consisting of Ge, Pb, Sn, Sb, Bi, Cu, and Mn, and X includes one or more selected from the group consisting of Cl, Br, and I, wherein the Cs 4 BX 6 perovskite luminescent nanocrystal has a pure phase, and a molar ratio of Cs to B (Cs/B) in the Cs 4 BX 6 perovskite luminescent nanocrystal is greater than 1 and less than 4.

First claim

Opening claim text (preview).

What is claimed is: 1. A perovskite luminescent nanocrystal represented by a chemical formula of: Cs 4 BX 6 , wherein B comprises one or more selected from the group consisting of Ge, Pb, Sn, Sb, Bi, Cu, and Mn, and X comprises one or more selected from the group consisting of Cl, Br, and I, wherein the Cs 4 BX 6 perovskite luminescent nanocrystal has a pure phase, and a molar ratio of Cs to B (Cs/B) in the Cs 4 BX 6 perovskite luminescent nanocrystal is greater than 1 and less than 4. 2. The perovskite luminescent nanocrystal of claim 1 , wherein a size of the perovskite luminescent nanocrystal is smaller than 500 nm. 3. A light emitting device comprising: a light emitting element configured to emit blue light or ultraviolet light; and a light emitting material, wherein the light emitting material comprises the perovskite luminescent nanocrystal of claim 1 , and the light emitting material is excited by the blue light or the ultraviolet light to emit first light rays. 4. The light emitting device of claim 3 , wherein when the perovskite luminescent nanocrystal is Cs 4 PbBr 6 , the first light rays have a peak wavelength ranged from 500 nm to 540 nm and an FWHM ranged from 10 nm to 30 nm. 5. The light emitting device of claim 3 , wherein the light emitting material further comprises one or more other wavelength converting materials. 6. The light emitting device of claim 5 , wherein the one or more wavelength converting materials are excited by the blue light or the ultraviolet light to emit second light rays. 7. The light emitting device of claim 6 , wherein a peak wavelength of the second light rays fall within a red wavelength range. 8. The light emitting device of claim 3 , wherein the light emitting element is a light emitting diode chip, a sub-millimeter light emitting diode chip, or a micro light emitting diode chip. 9. A manufacturing method for a perovskite luminescent nanocrystal comprising steps of: forming a cesium (Cs)-containing oleic acid precursor; mixing the cesium-containing oleic acid precursor, a non-polar solvent, and a first nucleating agent to form a first solution; adding BX 2 , a polar solvent, and a second nucleating agent to the first solution to form a second solution, wherein B comprises one or more selected from the group consisting of Ge, Pb, Sn, Sb, Bi, Cu, and Mn, and X comprises one or more selected from the group consisting of Cl, Br, and I; and stirring the second solution to form a perovskite luminescent nanocrystal represented by a chemical formula of: Cs 4 BX 6 , wherein B comprises one or more selected from the group consisting of Ge, Pb, Sn, Sb, Bi, Cu, and Mn, and X comprises one or more selected from the group consisting of Cl, Br, and I, wherein the Cs 4 BX 6 perovskite luminescent nanocrystal has a pure phase, and a molar ratio of Cs to B (Cs/B) in the Cs 4 BX 6 perovskite luminescent nanocrystal is greater than 1 and less than 4 by using an elemental analysis. 10. The manufacturing method of claim 9 , wherein the step of forming the cesium oleate precursor comprises: dissolving a cesium-containing precursor in oleic acid, wherein the cesium-containing precursor comprises cesium carbonate, cesium bromide, cesium oleylamine, or cesium oleate. 11. The manufacturing method of claim 9 , wherein the second solution is stirred in a nitrogen condition at a room temperature to form the perovskite luminescent nanocrystal. 12. The manufacturing method of claim 9 , wherein the step of forming the second solution further comprises adding a solubilizing agent, and the solubilizing agent is HX, wherein X is F, Cl, Br, or I. 13. The manufacturing method of claim 9 , wherein each of the first nucleating agent and the second nucleating agent comprises oleic acid, oleylamine, or a combination thereof. 14. The manufacturing method of claim 9 , wherein a polarity difference between the polar solvent and the non-polar solvent is greater than or equal to 3 and less than or equal to 10. 15. The manufacturing method of claim 14 , wherein when the polarity difference between the polar solvent and the non-polar solvent is greater than or equal to 3 and less than 6, the perovskite luminescent nanocrystal has a particle size between 100 nm and 500 nm is formed. 16. The manufacturing method of claim 14 , wherein when the polarity difference between the polar solvent and the non-polar solvent is greater than or equal to 6 and less than or equal to 10, the perovskite luminescent nanocrystal has a particle size between 10 nm and 100 nm is formed. 17. The manufacturing method of claim 9 , wherein the polar solvent is selected from the group consisting of isopropanol, Isobutyl alcohol, tetrafuran, water, acetone, methanol, ethanol, ethylene glycol, n-propanol, n-butanol, ethyl acetate, acetonitrile, dimethyl formamide, and dimethyl sulfoxide, and the non-polar solvent is selected from the group consisting of n-pentane, hexane, cyclohexane, benzene, toluene, p-xylene, and chlorobenzene. 18. The manufacturing method of claim 9 , wherein the elemental analysis comprises an energy-dispersive X-ray spectroscopy measurement, an inductively coupled plasma atomic emission spectroscopy measurement, or an inductively coupled plasma mass spectrometry measurement.

Assignees

Inventors

Classifications

  • of wavelength conversion means · CPC title

  • Wavelength conversion materials · CPC title

  • having two or more wavelength conversion materials · CPC title

  • Compounds containing lead, with or without oxygen or hydrogen, and containing two or more other elements · CPC title

  • Nanometer sized, i.e. from 1-100 nanometer · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10808172B2 cover?
A perovskite luminescent nanocrystal has a chemical formula represented by: Cs 4 BX 6 , wherein B includes one or more selected from the group consisting of Ge, Pb, Sn, Sb, Bi, Cu, and Mn, and X includes one or more selected from the group consisting of Cl, Br, and I, wherein the Cs 4 BX 6 perovskite luminescent nanocrystal has a pure phase, and a molar ratio of Cs to B (Cs/B) in the Cs 4 BX 6…
Who is the assignee on this patent?
Lextar Electronics Corp
What technology area does this patent fall under?
Primary CPC classification C09K11/665. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).